News and Events

Hatchtech Announces Successful Phase 3 Results

Posted: 2014-09-02 | Category: Press Releases

Specialty pharmaceutical company Hatchtech Pty Ltd today announced successful completion of its two pivotal Phase 3 clinical studies evaluating Xeglyze Lotion (formerly DeOvo Lotion) as a potential treatment for head lice infestation.

Categories